BNP Paribas Financial Markets Grows Stock Holdings in Azenta, Inc. (NASDAQ:AZTA)

BNP Paribas Financial Markets raised its holdings in Azenta, Inc. (NASDAQ:AZTA - Free Report) by 86.1% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 58,104 shares of the company's stock after purchasing an additional 26,877 shares during the quarter. BNP Paribas Financial Markets owned 0.13% of Azenta worth $2,905,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Picton Mahoney Asset Management lifted its holdings in shares of Azenta by 305.7% in the 4th quarter. Picton Mahoney Asset Management now owns 706 shares of the company's stock valued at $35,000 after buying an additional 532 shares during the period. Headlands Technologies LLC purchased a new position in Azenta in the fourth quarter worth $40,000. Covestor Ltd lifted its holdings in Azenta by 64.2% in the fourth quarter. Covestor Ltd now owns 2,043 shares of the company's stock valued at $102,000 after acquiring an additional 799 shares during the period. KBC Group NV lifted its holdings in Azenta by 48.5% in the fourth quarter. KBC Group NV now owns 2,137 shares of the company's stock valued at $107,000 after acquiring an additional 698 shares during the period. Finally, Quarry LP purchased a new stake in shares of Azenta during the 4th quarter worth $110,000. Institutional investors and hedge funds own 99.08% of the company's stock.

Azenta Trading Down 2.5%

Shares of NASDAQ AZTA traded down $0.71 during trading on Wednesday, reaching $27.56. The company had a trading volume of 152,600 shares, compared to its average volume of 679,684. Azenta, Inc. has a twelve month low of $23.91 and a twelve month high of $63.58. The stock has a 50-day moving average price of $29.62 and a two-hundred day moving average price of $41.35. The stock has a market capitalization of $1.26 billion, a PE ratio of -9.27 and a beta of 1.64.

Azenta (NASDAQ:AZTA - Get Free Report) last posted its quarterly earnings data on Wednesday, May 7th. The company reported $0.05 EPS for the quarter, missing analysts' consensus estimates of $0.09 by ($0.04). Azenta had a positive return on equity of 1.25% and a negative net margin of 24.91%. The business's revenue for the quarter was up 5.1% on a year-over-year basis. During the same period in the previous year, the firm posted $0.06 EPS. On average, sell-side analysts predict that Azenta, Inc. will post 0.53 EPS for the current year.

Analyst Ratings Changes

AZTA has been the subject of a number of research analyst reports. TD Cowen upgraded shares of Azenta to a "hold" rating in a report on Thursday, February 27th. Evercore ISI upped their target price on shares of Azenta from $50.00 to $52.00 and gave the stock an "in-line" rating in a research report on Thursday, February 6th. Finally, Needham & Company LLC reduced their price target on shares of Azenta from $59.00 to $40.00 and set a "buy" rating for the company in a research report on Wednesday, May 7th.

About Azenta

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.